<code id='92A6331693'></code><style id='92A6331693'></style>
    • <acronym id='92A6331693'></acronym>
      <center id='92A6331693'><center id='92A6331693'><tfoot id='92A6331693'></tfoot></center><abbr id='92A6331693'><dir id='92A6331693'><tfoot id='92A6331693'></tfoot><noframes id='92A6331693'>

    • <optgroup id='92A6331693'><strike id='92A6331693'><sup id='92A6331693'></sup></strike><code id='92A6331693'></code></optgroup>
        1. <b id='92A6331693'><label id='92A6331693'><select id='92A6331693'><dt id='92A6331693'><span id='92A6331693'></span></dt></select></label></b><u id='92A6331693'></u>
          <i id='92A6331693'><strike id='92A6331693'><tt id='92A6331693'><pre id='92A6331693'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:5
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          A Q&A with Aletha Maybank, AMA’s chief health equity officer
          A Q&A with Aletha Maybank, AMA’s chief health equity officer

          AlexHogan/STATIntheaftermathofthepolicemurderofGeorgeFloydandsubsequentBlackLivesMatterprotestsacros

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          In venture capital firm's success, lessons for turning crisis into profit

          AdobeThisarticleisadaptedfromSTAT’slatestreport,“2023Update:rankingbiotech’stopventurecapitalfirms.”